ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 36 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q4 2016. The put-call ratio across all filers is 2.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $441,000 | -8.1% | 139,864 | 0.0% | 0.00% | – |
| Q3 2016 | $480,000 | +2723.5% | 139,864 | +2195.5% | 0.00% | – |
| Q2 2016 | $17,000 | -54.1% | 6,093 | 0.0% | 0.00% | – |
| Q1 2016 | $37,000 | +12.1% | 6,093 | 0.0% | 0.00% | – |
| Q4 2015 | $33,000 | +22.2% | 6,093 | -11.9% | 0.00% | – |
| Q3 2015 | $27,000 | -6.9% | 6,918 | 0.0% | 0.00% | – |
| Q2 2015 | $29,000 | -62.3% | 6,918 | -64.6% | 0.00% | – |
| Q1 2015 | $77,000 | -81.0% | 19,522 | -70.3% | 0.00% | – |
| Q4 2014 | $405,000 | +33.7% | 65,689 | +1.3% | 0.00% | – |
| Q3 2014 | $303,000 | +39.0% | 64,833 | +43.2% | 0.00% | – |
| Q2 2014 | $218,000 | +45.3% | 45,289 | +92.1% | 0.00% | – |
| Q1 2014 | $150,000 | – | 23,574 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| A.R.T. Advisors, LLC | 20,419 | $16,000 | 0.09% |
| Maven Securities LTD | 1,000,000 | $795,000 | 0.07% |
| Verdence Capital Advisors LLC | 88,382 | $69,000 | 0.02% |
| Hayden Royal, LLC | 26,000 | $20,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 55,752 | $44,000 | 0.01% |
| Qube Research & Technologies Ltd | 519,063 | $407,000 | 0.01% |
| Virtu Financial LLC | 39,683 | $31,000 | 0.01% |
| Global Strategic Investment Solutions, LLC | 23,000 | $18,000 | 0.01% |
| Jacobi Capital Management LLC | 25,000 | $20,000 | 0.00% |
| RVW Wealth, LLC | 19,000 | $15,000 | 0.00% |